GLOBAL TYROSINE KINASE JAK INHIBITORS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Mar 2019 118

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.

These inhibitors have therapeutic application in the treatment of cancer and inflammatory diseases such as rheumatoid arthritis. There is interest in their use for various skin conditions. JAK3 inhibitors are attractive as a possible treatment of various autoimmune diseases since its functions is mainly restricted to lymphocytes. Development for a selective JAK3 inhibitors are ongoing.

In the report, we only count drugs for human beings. And the 1 unit is 1 tablet.

Scope of the Report:
Tyrosine Kinase JAK Inhibitors is widely used in Rheumatoid Arthritis (RA), Polycythemia Vera (PCV) and Myelofibrosis (MF). The most proportion of Tyrosine Kinase JAK Inhibitors is for Rheumatoid Arthritis (RA), and the proportion in 2017 is about 37%.
North America is the largest consumption place, with a consumption market share nearly 56% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 39%.
The worldwide market for Tyrosine Kinase JAK Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Tyrosine Kinase JAK Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Pfizer
- Incyte
- Novartis
- Eli Lilly
- Gilead
- Sanofi
- Galapagos
- AbbVie
- Vertex
- Teva
- Astellas Pharma
- Celgene
- CTI BioPharma

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Tofacitinib
- Ruxolitinib
- Baricitinib

Market Segment by Applications, can be divided into
- Rheumatoid Arthritis (RA)
- Polycythemia Vera (PCV)
- Myelofibrosis (MF)
- Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tyrosine Kinase JAK Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tyrosine Kinase JAK Inhibitors, with price, sales, revenue and global market share of Tyrosine Kinase JAK Inhibitors in 2017 and 2018.
Chapter 3, the Tyrosine Kinase JAK Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tyrosine Kinase JAK Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Tyrosine Kinase JAK Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Tyrosine Kinase JAK Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(Mar 19)

Glycoproteins are proteins that contain oligosaccharide chains (glycans) covalently attached to polypeptide side-chains. The carbohydrate is...

(Mar 19)

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both ...

(Mar 19)

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an o...

(Mar 19)

The global market is further analyzed by the following types: DNA microarray, flow cytometry, liquid chromatography, membrane filtration, pr...

(Mar 19)

A 3D cell culture is an artificially-created environment in which biological cells are permitted to grow or interact with their surroundings...

(Mar 19)

Restriction Endonuclease is an enzyme that cuts DNA at or near specific recognition nucleotide sequences known as restriction sites. They ar...

GLOBAL TYROSINE KINASE JAK INHIBITORS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Biotechnology market as per your needs. Get the best of Biotechnology research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy